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As I begin my term as President of the ISSCR, I would like to con-
gratulate my predecessor, George Daley, on guiding the society
through a successful and eventful year. The launch of Cell Stem
Cell has been a great success; the journal not only publishes
outstanding research papers but also provides a forum for
the ISSCR to cover topics of interest to our membership and
the wider stem cell community. The Global Advisory Council,
made up of leaders in business and policy, was established
and at its first meeting provided the ISSCR with expert advice
on strategies for effective engagement with the media. The
ISSCRwas involved in last year’s Shanghai International Sympo-
sium on Stem Cell Research, and as I write this, we are looking
forward to the 6th ISSCR Annual Meeting in Philadelphia. Regis-
trations are still coming in, but we know already that this will be
our largest meeting ever and that the program is superb.
So what are our goals for the coming year? Ongoing activities
of the society will continue to be expertly handled by our different
committees, one example being the establishment of an ISSCR
Registry of Human Embryonic Stem Cell Line Provenance. We
will continue to develop the Global Advisory Council, and we
will do our best to ensure the society’s long-term financial stabil-
ity, because this is necessary to underpin new initiatives. As the
annual meeting grows in size, we feel there may be additional
benefit in organizing smaller, more focused workshops. Out-
reach will be an important ISSCR objective, both through
strengthening our links with other groups involved in stem cell
research and through forging new links with researchers in re-
lated areas, such as biomaterials. We are committed to fostering
translation of basic stem cell research into the clinic and hope to
strengthen this part of our mission by maximizing the opportuni-
ties for dialogue between the research and clinical communities.
And, of course, we are already preparing for the ISSCR 7th
Annual Meeting in
2009 in Barcelona. I
am delighted that
Ron McKay has taken
on the role of Annual
Meeting Program
Committee Chair, as I
know that under his
guidance the program
will be exciting and in-
novative. This will be
the first time that an
ISSCR meeting has
been held in Europe
and is an opportunity
for the society to widen
its appeal to re-
searchers in Europe.
The most effective
way to do this is simply
by drawing a large
number of researchers
together in Barcelona,
highlighting local science, and the scope and activities of the
society.
What is special about stem cell research in Europe? One an-
swer is that the different European countries have different cul-
tures and therefore approaches to regulating stem cell research.
A second answer is that most research is carried out in countries
that are members of the European Union (EU). EU-funded
research activities offer tremendous scope for collaborations
between researchers in different countries, and stem cell re-
searchers have been benefiting from this for a number of years.
As an example of the British approach to regulating stem cell
research, the Human Fertilisation and Embryology Bill is being
debated in parliament as I write this. The bill covers some topics
that are outside most researchers’ expertise or do not intrinsi-
cally affect scientific research. However, there are other aspects
about which the research community most definitely wishes to
comment: the creation of ‘‘human admixed embryos’’ (interspe-
cies embryos) and removing the prohibition on altering the ge-
netic structure of embryos for research. It is said that trying to
get academics to agree to anything is like herding cats; however,
when it comes to legislation in the UK, the major biomedical
funding agencies and learned societies are very effective at
mobilizing the scientific community to speak with a common
voice. The Wellcome Trust, for example, has featured the bill
prominently on its website (http://www.wellcome.ac.uk/) and
provides a range of resources, such as an explanation in lay
terms of admixed embryos, which aspects of the bill the Trust
supports, interviews with scientists, and briefing notes for politi-
cians. This type of resource is invaluable in helping scientists to
lobby for effective legislation. There is no doubt that, world-wide,
stem cell researchers should not be silent in the face of political
debate, but engage with the public and with legislators to pro-
vide balanced scien-
tific input on the issues
under discussion.
When it comes to EU
funding for research,
the driver is overtly po-
litical. Research fund-
ing iscentral to theEU’s
strategy to become the
‘‘most dynamic com-
petitive knowledge-
based economy in the
world’’ (California take
note!). The current
funding cycle is known
as the Seventh Frame-
work Programme (FP7)
(http://cordis.europa.eu/
fp7/home_en.html) and
will distribute up to
V50,521 million during
2007–2013. Calls for
proposals in specific
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stakeholders, in particular the European Parliament, the scien-
tific community, and industry. Once a call is announced, scien-
tists contact one another andwork together to put forward a pro-
posal. There is a strong incentive to have a good geographical
spread and to include partners in industry. EU funding provides
money for postdocs to work in individual labs, but there is also an
emphasis on travel, training, and workshops. We all complain
about the bureaucracy, such as providing signed time sheets
for staff employed with EU funds. However, the benefits far out-
weigh the disadvantages: scientists within a network think and
work collaboratively, share resources, train the next generation
of researchers, and consider commercial exploitation at an early
stage in the research.
Some ISSCR members will have heard of EuroStemCell, a
project that was funded as part of the European Union’s Sixth
Framework Programme, with Austin Smith as coordinator. Be-
tween 2004 and 2008 the EU provided V11.9 million support to
27 laboratories to cover basic, applied, clinical, and ethical
research in stem cells. Outputs from EuroStemCell include an
annual summer school for stem cell researchers and a series
of award-winning movies that explain stem cell research to the
public. The final meeting of EuroStemCell researchers in Brus-
sels last December featured a debate in the European Parliament
and brought home the particular challenges of engaging directly
with politicians.
If there is a lesson for the wider stem cell community from the
EU research fundingmodel, it is the benefit of large-scale collab-
orations between groups of scientists. Many of the networks put
together with EU funding evolve into long-term collaborations
that extend well beyond the original funding period.
In this note I have summarized some of the recent successes
and future challenges for ISSCR and provided some flavor of
stem cell research in Europe. I look forward to working with the
ISSCR staff, particularly NancyWitty, as well as the ISSCR board
and various committees to ensure that ISSCR continues to
prosper. Please don’t be shy about contacting me with any
suggestions and comments.
Fiona M. Watt
President, ISSCR
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